{"SPADE_UN_17033": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17033", "Peptide Name": "YTA4", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "IAWVKAFIRKLRKGPLG", "Sequence Length": 17, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "fluorescein", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C94H157N27O18", "Mass": 1953.42, "PI": 12.0, "Net Charge": 5, "Hydrophobicity": 0.19, "Half Life": "Mammalian:20 hourYeast:30 minE.coli:>10 hour", "Literature": [{"Title": "Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide.", "Pubmed ID": "16376307", "Reference": "Biochem Pharmacol. 2006 Feb 14;71(4)416-25.", "Author": "Lindgren M, Rosenthal-Aizman K, Saar K, Eiríksdóttir E, Jiang Y, Sassian M, Ostlund P, Hällbrink M, Langel U.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16376307"}], "Frequent Amino Acids": "KAG", "Absent Amino Acids": "CDEHMNOQSTUY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 10, "Polar Residues": 8, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_16995", "Similarity": 1.0, "Sequence": "YTAIAWVKAFIRKLRK"}, {"SPADE_ID": "SPADE_UN_10127", "Similarity": 0.6, "Sequence": "IINFYDPLVFPSDEFDASISQVNEKINQSLAFIRK"}, {"SPADE_ID": "SPADE_UN_10492", "Similarity": 0.6, "Sequence": "FYDPLVFPSDEFDASISQVNEKINQSLAFIRK"}]}}}